More than a million people with heart disease are to be prescribed the weight loss jab Wegovy to prevent them from having heart attacks or strokes.
The NHS’s spending watchdog, the National Institute for Health and Care Excellence (Nice), has given the green light to giving semaglutide to overweight and obese patients living with certain heart and circulatory conditions to cut their risk of a major cardiovascular event.
